tiprankstipranks
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
RESEARCH TOOLSreports

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Income Statement

2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Income Statement

Last quarter (Q4 2025), Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total revenue was ¥1.28B, an increase of 6.00% from the same quarter last year. In Q4, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's net income was ¥-204.09M. See Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
¥ 5.48B¥ 5.28B¥ 5.45B¥ 7.16B¥ 6.37B
Gross Profit
¥ 1.74B¥ 1.76B¥ 1.80B¥ 2.33B¥ 2.03B
Operating Expenses
¥ 1.11B¥ 1.01B¥ 2.66B¥ 1.21B¥ 1.07B
Depreciation and Amortization
¥ 372.91M¥ 331.05M¥ 373.60M¥ 307.66M¥ 302.74M
EBITDA
¥ 846.59M¥ 1.20B-¥ 1.37B¥ 726.64M
Operating Income
¥ 635.97M¥ 741.31M¥ -238.11M¥ 1.14B¥ 773.20M
Other Income/Expenses
¥ -233.73M¥ -15.08M-¥ -168.70M¥ -611.27M
Pretax Income
¥ 402.24M¥ 726.23M-¥ 829.85M¥ 222.26M
Net Income
¥ 349.49M¥ 646.74M-¥ 727.43M¥ 240.79M
Per Share Metrics
Basic EPS
¥ 0.24¥ 0.44¥ -0.53¥ 0.50¥ 0.16
Diluted EPS
¥ 0.24¥ 0.44¥ -0.53¥ 0.50¥ 0.16
Weighted Average Shares Outstanding
 1.47B 1.47B 1.47B 1.47B 1.47B
Weighted Average Shares Outstanding (Diluted)
 1.47B 1.47B 1.47B 1.47B 1.47B
Currency in CNY

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Earnings and Revenue History